Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) CEO Brent Willis tells Proactive's Stephen Gunnion that the company has completed the design of its carbon-neutral pharmaceutical plant, accelerating the revenue generation timeline for its Frances Creek barium sulphate project.
Willis says building the first carbon-neutral pharmaceutical facility in Alberta would be a major milestone for Voyageur, with the added benefit of de-carbonizing the company's customer base by utilizing its carbon credits to make its product line unique and attractive to ensure potential high growth.